|1.||Fu, Allie: 1 article (01/2011)|
|2.||Baldwin, Ronald M: 1 article (01/2011)|
|3.||Peterson, Todd E: 1 article (01/2011)|
|4.||Colvin, Daniel: 1 article (01/2011)|
|5.||Hight, Matthew R: 1 article (01/2011)|
|6.||Guleryuz, Saffet: 1 article (01/2011)|
|7.||Buck, Jason R: 1 article (01/2011)|
|8.||McKinley, Eliot T: 1 article (01/2011)|
|9.||Smith, Ralph Adam: 1 article (01/2011)|
|10.||Zhao, Ping: 1 article (01/2011)|
01/01/2011 - "These preclinical studies illustrate that 18F-PBR06 is a promising tracer for visualization of TSPO-expressing tumors. "
01/01/2011 - "These data suggest the potential of 18F-PBR06 to elucidate the role of TSPO in oncology, as well as its potential development as a cancer imaging biomarker."
01/01/2011 - "The accumulation of 18F-PBR06 in tumor tissues and adjacent brain agreed with the ex vivo assay of TSPO protein levels by Western blotting and quantitative immunohistochemistry. "
01/01/2011 - "18F-PBR06 was found to preferentially accumulate in tumors, with modest uptake in the contralateral brain, facilitating excellent contrast between tumor and adjacent tissue. "
01/01/2011 - "Specific tumor cell binding of PBR06 was evaluated by radioligand displacement of 3H-PK 11195 with PBR06 in vitro and by displacement of 18F-PBR06 with excess PBR06 in vivo. "
01/01/2011 - "Glioma-bearing rats were imaged with 18F-PBR06 in a small-animal PET system. "
01/01/2011 - "Importantly, the close correlation between 18F-PBR06 uptake and TSPO expression in tumors and normal tissues, coupled with the high degree of displaceable binding from both tumors and the normal brain, represents a significant improvement over other TSPO imaging ligands previously evaluated in glioma. "